- Home
- SSBK vs CYRX Comparison
SSBK vs CYRX Comparison
Compare SSBK & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSBK
- CYRX
- Stock Information
- Founded
- SSBK 2007
- CYRX 1999
- Country
- SSBK United States
- CYRX United States
- Employees
- SSBK N/A
- CYRX N/A
- Industry
- SSBK Commercial Banks
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- SSBK Finance
- CYRX Health Care
- Exchange
- SSBK Nasdaq
- CYRX Nasdaq
- Market Cap
- SSBK 355.8M
- CYRX 381.6M
- IPO Year
- SSBK 2021
- CYRX N/A
- Fundamental
- Price
- SSBK $34.41
- CYRX $7.86
- Analyst Decision
- SSBK Buy
- CYRX Buy
- Analyst Count
- SSBK 1
- CYRX 7
- Target Price
- SSBK $36.00
- CYRX $13.14
- AVG Volume (30 Days)
- SSBK 20.4K
- CYRX 446.9K
- Earning Date
- SSBK 01-21-2025
- CYRX 11-07-2024
- Dividend Yield
- SSBK 1.05%
- CYRX N/A
- EPS Growth
- SSBK N/A
- CYRX N/A
- EPS
- SSBK 3.52
- CYRX N/A
- Revenue
- SSBK $87,115,000.00
- CYRX $226,113,000.00
- Revenue This Year
- SSBK N/A
- CYRX N/A
- Revenue Next Year
- SSBK $11.75
- CYRX $7.92
- P/E Ratio
- SSBK $9.78
- CYRX N/A
- Revenue Growth
- SSBK 1.89
- CYRX N/A
- 52 Week Low
- SSBK $22.13
- CYRX $5.32
- 52 Week High
- SSBK $39.16
- CYRX $20.11
- Technical
- Relative Strength Index (RSI)
- SSBK 44.38
- CYRX 53.97
- Support Level
- SSBK $34.77
- CYRX $7.44
- Resistance Level
- SSBK $36.41
- CYRX $8.37
- Average True Range (ATR)
- SSBK 1.25
- CYRX 0.63
- MACD
- SSBK -0.50
- CYRX 0.02
- Stochastic Oscillator
- SSBK 41.95
- CYRX 51.66
About SSBK Southern States Bancshares Inc.
Southern States Bancshares Inc is a full-service community banking institution, that offers an array of deposit, loan, and other banking-related products and services to businesses and individuals in communities. It has three portfolio segments Real estate, Commercial and industrial, Consumer and other.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.